Chondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo

Recently, we described a peptide-modified AAV2 vector (AAV-GMN) containing a capsid-displayed peptide that directs in vivo brain vascular targeting and transduction when delivered intravenously. In this study, we sought to identify the receptor that mediates transduction by AAV-GMN. We found that AA...

Descripción completa

Detalles Bibliográficos
Autores principales: Geoghegan, James C, Keiser, Nicholas W, Okulist, Anna, Martins, Inês, Wilson, Matthew S, Davidson, Beverly L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217075/
https://www.ncbi.nlm.nih.gov/pubmed/25313621
http://dx.doi.org/10.1038/mtna.2014.50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217075/
https://www.ncbi.nlm.nih.gov/pubmed/25313621
http://dx.doi.org/10.1038/mtna.2014.50

Ejemplares similares